1. Home
  2. HOUR vs ATNM Comparison

HOUR vs ATNM Comparison

Compare HOUR & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$2.00

Market Cap

72.5M

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.50

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
ATNM
Founded
2015
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.5M
50.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
HOUR
ATNM
Price
$2.00
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
42.1K
224.5K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$140,790,433.00
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$42,943.57
P/E Ratio
$83.79
N/A
Revenue Growth
N/A
11.11
52 Week Low
$1.10
$1.03
52 Week High
$6.90
$2.41

Technical Indicators

Market Signals
Indicator
HOUR
ATNM
Relative Strength Index (RSI) 45.97 59.46
Support Level $1.99 $1.37
Resistance Level $2.11 $1.54
Average True Range (ATR) 0.11 0.08
MACD 0.02 0.02
Stochastic Oscillator 46.81 82.35

Price Performance

Historical Comparison
HOUR
ATNM

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: